Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
Durlik
M
M
Transplantation Institute, Warsaw Medical School, Poland.
Gaciong
Z
Z
Soluch
L
L
Rowińska
D
D
Kozłowska-Boszko
B
B
Rowiński
W
W
Szmidt
J
J
Lao
M
M
D000293:Adolescent; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006509:Hepatitis B / Q000150:complications*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006526:Hepatitis C / Q000150:complications*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies